Peaks of Interest
Malvern Instruments Acquires Viscotek Corporation; Thermo Fisher Scientific Wins 2007 Frost and Sullivan Award; The Kinesis Group Acquires Abimed Analysen
Malvern Instruments Acquires Viscotek Corporation
Malvern Instruments (UK), a materials characterization company, announced its acquisition of Viscotek Corporation, a leading provider of chromatography solutions for the characterization of natural and synthetic polymers and proteins. Viscotek will bring new and complementary technologies and expertise to Malvern, adding gel permeation chromatography (GPC), flow injection polymer analysis (FIPA) and dilute solution viscosity (DSV), and extending the range of characterization solutions offered.
Viscotek Corporation, based in Houston, Texas, was founded in 1984 by Dr. Max Haney, inventor of the four-capillary differential viscometer detector. According to Paul Walker, Malvern's managing director, the alignment of Viscotek's products with Malvern's range will provide even more opportunity to comprehensively meet a broad range of customer needs. Viscotek's present management will continue to lead the business, which will operate as Viscotek Corporation, a Malvern Company.
Thermo Fisher Scientific Wins 2007 Frost & Sullivan Award
Thermo Fisher Scientific, Inc. (Waltham, Massachusetts) has been honored with the 2007 Frost & Sullivan Market Leadership Award for its outstanding contribution to the US High Content Screening (HCS) market. This award credits the company's expertise, insight into customer requirements, and technological innovation and advanced solutions for cell-based screening and analysis. Frost & Sullivan has identified Thermo Fisher as excellent in all areas of market leadership due to their ability to monitor market changes and implement strategies to meet the rapidly changing industry demands.
The Kinesis Group Acquires Abimed Analysen
The Kinesis group of companies (UK) announced its acquisition of Abimed Analysen, a German-based company focused on the chromatography and liquid handling markets.
According to the company, the acquisition of Abimed will provide the Kinesis group with an excellent platform to penetrate Europe's largest market.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
